Drug profile · INN
zanidatamab-hrii
ZIIHERA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
zanidatamab-hrii (ZIIHERA) is an FDA-listed pharmaceutical active ingredient. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN zanidatamab-hrii
Brand ZIIHERA
Route INJECTION
Formulation INJECTABLE
Originator Jazz Pharmaceuticals Ireland Limited
Frequently asked questions
What is zanidatamab-hrii?
zanidatamab-hrii (ZIIHERA) is an FDA-listed pharmaceutical active ingredient. Associated with Jazz Pharmaceuticals Ireland Limited. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for zanidatamab-hrii?
ZIIHERA is a marketed brand name for zanidatamab-hrii. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of zanidatamab-hrii?
zanidatamab-hrii has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.